https://www.selleckchem.com/pr....oducts/adenosine-cyc
This nanosensor was realized in certain living cells (HepG2, HeLa and A549). Based on monitoring the activation of specific apoptotic markers, the conduction of marker signals in real time can provide more detailed information for apoptosis. Agents targeting programmed cell death protein 1 (PD-1) have been approved as monotherapy for patients with small cell lung cancer (SCLC). In preclinical models, the combined targeting of PD-1 and delta-like protein 3 resulted in enhanced antitumor activity. Herein, we report result
Aimer
Commentaire
Partagez
